The capital will be used to start clinical development of a technique developed at Columbia University that could help tackle heart and metabolic diseases.
Applied Therapeutics, a US-based pharmaceuticals spinout from Columbia University, closed its series A round today led by Alexandria Venture Investments, the investment arm of life science real estate provider Alexandria Real Estate Equities.
Additional investors included E Squared Capital Management, ETP Global Fund and Syno Capital, as well as individual backer Franklin Berger.
The size of the round has not been disclosed, though a regulatory filing reveals Applied was seeking a $7m investment.
Applied Therapeutics is working on technology to…
